Related Experiment Videos
Hidradenitis suppurativa managed with adalimumab
1Dermatology Institute and Skin Care Center, Santa Monica, CA 90404, USA. paulyamauchi@yahoo.com
Journal of Drugs in Dermatology : JDD
|February 14, 2009
Summary
Hidradenitis suppurativa (HS) is a chronic skin condition. Adalimumab, a TNF antagonist, shows promise in resolving HS lesions when other treatments fail.
Area of Science:
- Dermatology
- Immunology
Background:
- Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease affecting apocrine glands, often seen in women aged 20-40.
- Patients experience discomfort, itching, papules, nodules, and potential abscess/sinus tract formation.
Observation:
- Adalimumab, a tumor necrosis factor (TNF) antagonist, has emerged as a potential treatment for HS.
- Three patients with HS refractory to conventional therapy showed resolution of skin lesions after adalimumab treatment.
Findings:
- Adalimumab treatment led to the resolution of skin lesions in patients with hidradenitis suppurativa.
- Patients reported convenience with at-home administration of adalimumab.
- One patient avoided surgery due to the effectiveness of TNF-antagonist therapy.
Implications:
- Adalimumab may offer an effective treatment option for hidradenitis suppurativa when conventional therapies are unsuccessful.
- Further research is needed to establish the efficacy and safety profile of adalimumab for HS management.
Related Concept Videos
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:17Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...